Tumors B 7-H 4 ( B 7 x ) – Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL 6 / JAK / STAT 3 Pathway Lead to Poor Prognosis in Glioma Patients

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• B7-H4 Expression Is Associated with Tumor Progression and Prognosis in Patients with Osteosarcoma

  2015cited by this paper
• Diagnostic value of serum B7-H4 for hepatocellular carcinoma.

  2015cited by this paper
• Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer

  2014cited by this paper
• Structure and cancer immunotherapy of the B7 family member B7x.

  2014influential reference
• B7-H4 expression in bladder urothelial carcinoma and immune escape mechanisms

  2014cited by this paper
• B7-H4 Expression by Nonhematopoietic Cells in the Tumor Microenvironment Promotes Antitumor Immunity

  2014cited by this paper
• B7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium

  2013cited by this paper
• Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells

  2013cited by this paper
• Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas

  2012cited by this paper
• Defining the mode of tumour growth by clonal analysis

  2012cited by this paper
• Cellular constituents of immune escape within the tumor microenvironment.

  2012cited by this paper
• Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients

  2012cited by this paper
• Coordinated regulation of myeloid cells by tumours

  2012cited by this paper
• Mechanisms of immune evasion by gliomas.

  2012cited by this paper
• A restricted cell population propagates glioblastoma growth after chemotherapy

  2012cited by this paper
• Cancer stem cells: an evolving concept

  2012cited by this paper
• Microglia/macrophages promote glioma progression

  2011cited by this paper
• B7-H4 Expression in Human Melanoma: Its Association with Patients' Survival and Antitumor Immune Response

  2011cited by this paper
• Glioma cancer stem cells induce immunosuppressive macrophages/microglia.

  2010cited by this paper
• Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages

  2010cited by this paper
• B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells.

  2009cited by this paper
• CD8+ T cell efficacy in vaccination and disease

  2008cited by this paper
• Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage.

  2008cited by this paper
• B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells

  2008cited by this paper
• B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

  2007cited by this paper
• Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

  2007cited by this paper
• CD8+ T‐cell memory in tumor immunology and immunotherapy

  2006cited by this paper
• B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer.

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.

  2003cited by this paper
• Cancerous stem cells can arise from pediatric brain tumors

  2003cited by this paper
• Identification of a cancer stem cell in human brain tumors.

  2003cited by this paper
• B7S1, a novel B7 family member that negatively regulates T cell activation.

  2003cited by this paper
• B7x: A widely expressed B7 family member that inhibits T cell activation

  2003cited by this paper
• Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study.

  2000cited by this paper
• The cell biology of the blood-brain barrier.

  1999cited by this paper
• JAKs, STATs and signal transduction in response to the interferons and other cytokines.

  1996cited by this paper

• The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6/JAK/STAT3 Signaling Pathway

  2023cites this paper
• AURKA inhibitor-induced PD-L1 upregulation impairs antitumor immune responses

  2023cites this paper
• The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma

  2023cites this paper
• Platelet Activating Factor Receptor Exaggerates Microglia-Mediated Microenvironment by IL10-STAT3 Signaling: A Novel Potential Biomarker and Target for Diagnosis and Treatment of Alzheimer’s Disease

  2022cites this paper
• B7 Family Members in Pancreatic Ductal Adenocarcinoma: Attractive Targets for Cancer Immunotherapy

  2022cites this paper
• APOL4, a Novel Immune-Related Prognostic Biomarker for Glioma

  2022cites this paper
• Exosomal B7–H4 from irradiated glioblastoma cells contributes to increase FoxP3 expression of differentiating Th1 cells and promotes tumor growth

  2022cites this paper
• The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: A Scoping Review

  2021cites this paper
• Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma

  2021cites this paper
• The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure

  2021cites this paper
• Modulation of Immune Components on Stem Cell and Dormancy in Cancer

  2021cites this paper
• Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors

  2020cites this paper
• T lymphocyte-targeted immune checkpoint modulation in glioma

  2020cites this paper
• HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma

  2020cites this paper
• Dp44mT, an iron chelator, suppresses growth and induces apoptosis via RORA-mediated NDRG2-IL6/JAK2/STAT3 signaling in glioma

  2020cites this paper
• Negative regulators of STAT3 signaling pathway in cancers

  2019cites this paper
• Cellular crosstalk mediating immune evasion in pancreatic cancer microenvironment

  2019cites this paper
• Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis

  2019cites this paper
• The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy

  2019cites this paper
• Expression of inhibitory checkpoint ligands by Glioblastoma Multiforme cells and the implications of an enhanced stem cell-like phenotype

  2019cites this paper
• Immune Cell Gene Signatures for Profiling the Microenvironment of Solid Tumors

  2018cites this paper
• Expression and clinical significance of negative costimulatory molecules B7-H1, B7-H3 and B7-H4 in the process of colorectal cancer’s evolution

  2018cites this paper